PeptiDream Inc (PPTDF)
9.50
0.00 (0.00%)
USD |
OTCM |
Apr 24, 16:00
PeptiDream Cash from Financing (TTM): 1.883M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 1.883M |
September 30, 2023 | -12.46M |
June 30, 2023 | -23.72M |
March 31, 2023 | -40.19M |
December 31, 2022 | 159.43M |
September 30, 2022 | 151.67M |
June 30, 2022 | 166.57M |
March 31, 2022 | 191.40M |
December 31, 2021 | 0.6021M |
September 30, 2021 | 0.4156M |
June 30, 2021 | 0.3871M |
March 31, 2021 | -2.097M |
December 31, 2020 | -2.223M |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
September 30, 2019 | |
June 30, 2019 | 0.2567M |
March 31, 2019 | 0.101M |
Date | Value |
---|---|
December 31, 2018 | 1.088M |
September 30, 2018 | 1.081M |
June 30, 2018 | 1.544M |
March 31, 2018 | 1.600M |
December 31, 2017 | 1.348M |
September 30, 2017 | -2.162M |
June 30, 2017 | 0.4186M |
March 31, 2017 | 6.055M |
December 31, 2016 | 14.56M |
September 30, 2016 | 18.08M |
June 30, 2016 | 14.96M |
March 31, 2016 | 9.324M |
December 31, 2015 | 0.1198M |
September 30, 2015 | 0.1107M |
June 30, 2015 | 0.3887M |
March 31, 2015 | 0.3876M |
December 31, 2014 | 0.2894M |
September 30, 2014 | 0.3459M |
June 30, 2014 | 0.1817M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-40.19M
Minimum
Mar 2023
191.40M
Maximum
Mar 2022
42.28M
Average
0.4013M
Median
Cash from Financing (TTM) Benchmarks
Takeda Pharmaceutical Co Ltd | -2.274B |
Nxera Pharma Co Ltd | 344.46M |
Stemcell Holdings Inc | -0.0934M |
Healios KK | 23.78M |
AnGes Inc | -- |